GlassScriptPhysician profile
David Paul Mosch
NPI 1366483687
$9,456.49
in general payments reported to CMS, 2019-2025
46 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,379 · 2020: $1,169 · 2021: $1,495 · 2022: $1,429 · 2023: $1,522 · 2024: $1,449 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,872 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,872.33 |
| Education | $111.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,515.69 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,111.39 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,027.34 | 2019-2025 | Jardiance, Synjardy |
| Pfizer INC. | $845.14 | 2019-2024 | |
| Abbvie INC. | $758.68 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $522.26 | 2019-2025 | Gardasil 9, Verquvo, Belsomra |
| Glaxosmithkline, LLC. | $513.55 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $475.13 | 2020-2025 | Mounjaro, Kisunla, Jardiance |
| Exact Sciences Corporation | $264.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $211.18 | 2021-2025 | |
| Abbott Laboratories | $200.75 | 2022-2025 | Freestyle Libre 3 |
| Eisai INC. | $189.73 | 2020-2024 | |
| Amgen INC. | $177.61 | 2019-2025 | Repatha, Otezla, Otezla |
| Astellas Pharma US INC | $173.53 | 2020-2024 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $136.29 | 2019-2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mosch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.